Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022
MicroPulse® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways to manage, preserve, and prolong vision for glaucoma patients.
Related news for (IRIX)
- Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
- Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
- Iridex Announces Strategic Investment in the Company
- Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
- Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management